PERSPECTIVE THERAPEUTICS INC.
NYSE: CATX (Perspective Therapeutics, Inc.)
最近更新时间: 5小时之前3.17
-0.05 (-1.55%)
| 前收盘价格 | 3.22 |
| 收盘价格 | 3.16 |
| 成交量 | 815,716 |
| 平均成交量 (3个月) | 989,971 |
| 市值 | 235,303,728 |
| 股市价格/股市净资产 (P/B) | 0.860 |
| 52周波幅 | |
| 利润日期 | 12 May 2025 |
| 营业利益率 (TTM) | -6,383.63% |
| 稀释每股收益 (EPS TTM) | -1.18 |
| 季度收入增长率 (YOY) | 5.20% |
| 总债务/股东权益 (D/E MRQ) | 1.34% |
| 流动比率 (MRQ) | 17.02 |
| 营业现金流 (OCF TTM) | -53.72 M |
| 杠杆自由现金流 (LFCF TTM) | -87.14 M |
| 资产报酬率 (ROA TTM) | -15.56% |
| 股东权益报酬率 (ROE TTM) | -32.92% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 看跌 | 混合的 |
| Medical Devices (全球的) | 看跌 | 混合的 | |
| 股票 | Perspective Therapeutics, Inc. | - | - |
AIStockmoo 评分
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | -0.50 |
|
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 内部持股比例 | 18.83% |
| 机构持股比例 | 61.15% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 31 Mar 2025 | 2,829,413 |
| Octagon Capital Advisors Lp | 31 Mar 2025 | 2,250,000 |
| Affinity Asset Advisors, Llc | 31 Mar 2025 | 2,224,196 |
| Avidity Partners Management Lp | 31 Mar 2025 | 2,197,270 |
| Nicholson Wealth Management Group, Llc | 31 Mar 2025 | 1,609,283 |
| Vestor Capital, Llc | 31 Mar 2025 | 974,720 |
| Ghost Tree Capital, Llc | 30 Sep 2024 | 750,000 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合